Cargando…

A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses

Hypoxia is an important feature of the tumor microenvironment(TME) and is closely associated with cancer metastasis, immune evasion, and drug resistance. However, the precise role of hypoxia in hepatocellular carcinoma(HCC), as well as its influence on the TME, and drug sensitivity remains unclear....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Guangzhen, Zhu, Jinghan, Ning, Deng, Li, Ganxun, Zhang, Yuxin, Xiong, Yixiao, Liang, Junnan, Yu, Chengpeng, Chen, Xiaoping, Liang, Huifang, Ding, Zeyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428591/ https://www.ncbi.nlm.nih.gov/pubmed/36059442 http://dx.doi.org/10.3389/fimmu.2022.997316

Ejemplares similares

Pan-cancer analysis of the prognostic value of C12orf75 based on data mining
por: Cai, Guangzhen, et al.
Publicado: (2021)

Comprehensive analysis of TGF-β-induced mRNAs and ncRNAs in hepatocellular carcinoma
por: Liang, Junnan, et al.
Publicado: (2020)

Immunological Role and Prognostic Value of APBB1IP in Pan-Cancer Analysis
por: Ge, Qianyun, et al.
Publicado: (2021)

Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022)

The Roles of TIF1γ in Cancer
por: Yu, Chengpeng, et al.
Publicado: (2019)

IMOPAC: A web server for interactive multiomics and pharmacological analyses of patient-derived cancer cell lines
por: Li, Ganxun, et al.
Publicado: (2023)

The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway
por: Song, Jia, et al.
Publicado: (2021)

The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors
por: Zhu, Jinghan, et al.
Publicado: (2020)

CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1
por: Liao, Jingyu, et al.
Publicado: (2023)

Pan-cancer analysis of promoter activity quantitative trait loci
por: Li, Ran, et al.
Publicado: (2023)

Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
por: Wang, Yuxin, et al.
Publicado: (2023)

Alkaline phosphatase combined with γ-glutamyl transferase is an independent predictor of prognosis of hepatocellular carcinoma patients receiving programmed death-1 inhibitors
por: Xu, Lei, et al.
Publicado: (2023)

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2021)

Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2023)

TDO2 Was Downregulated in Hepatocellular Carcinoma and Inhibited Cell Proliferation by Upregulating the Expression of p21 and p27
por: Yu, Chengpeng, et al.
Publicado: (2021)

Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma
por: Mo, Zhuomao, et al.
Publicado: (2021)

Serum amylase elevation is associated with adverse clinical outcomes in patients with coronavirus disease 2019
por: Li, Ganxun, et al.
Publicado: (2021)

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma
por: Cai, Jialiang, et al.
Publicado: (2022)

DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6
por: Zhang, Xiaochao, et al.
Publicado: (2022)

Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma
por: Luo, Yiming, et al.
Publicado: (2021)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Yan, Zongcai, et al.
Publicado: (2021)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Predicting the prognosis in patients with sepsis by a pyroptosis-related gene signature
por: Liang, Shuang, et al.
Publicado: (2022)

Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma
por: Tan, Xiaolong, et al.
Publicado: (2018)

Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature
por: Zhang, Ze, et al.
Publicado: (2022)

Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer
por: Lu, Hongcheng, et al.
Publicado: (2022)

Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients
por: Zhang, Zi-jian, et al.
Publicado: (2023)

Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma
por: Li, Ganxun, et al.
Publicado: (2019)

Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma
por: Xu, Weifeng, et al.
Publicado: (2022)

A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients
por: Yuan, Jingsheng, et al.
Publicado: (2022)

Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma
por: Wang, Zhijian, et al.
Publicado: (2023)

The m(6)A-related gene signature stratifies poor prognosis patients and characterizes immunosuppressive microenvironment in hepatocellular carcinoma
por: Ma, Ensi, et al.
Publicado: (2023)

The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma
por: Yao, Kai, et al.
Publicado: (2023)

Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
por: Peng, Xingyu, et al.
Publicado: (2022)

Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma
por: Li, Yue, et al.
Publicado: (2022)

Genome‐wide identification of a competing endogenous RNA network in cholangiocarcinoma
por: Li, Ganxun, et al.
Publicado: (2019)

Bone Lesion‐Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5‐Targeting miR‐3190‐5p
por: Han, Shenqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u3c8isjjccnp3o21qhe6cru0b9